Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Nature. 2017 Jan 12;541(7636):228-232. doi: 10.1038/nature21034. Epub 2016 Dec 26.
Although long non-coding RNAs (lncRNAs) are non-protein-coding transcripts by definition, recent studies have shown that a fraction of putative small open reading frames within lncRNAs are translated. However, the biological significance of these hidden polypeptides is still unclear. Here we identify and functionally characterize a novel polypeptide encoded by the lncRNA LINC00961. This polypeptide is conserved between human and mouse, is localized to the late endosome/lysosome and interacts with the lysosomal v-ATPase to negatively regulate mTORC1 activation. This regulation of mTORC1 is specific to activation of mTORC1 by amino acid stimulation, rather than by growth factors. Hence, we termed this polypeptide 'small regulatory polypeptide of amino acid response' (SPAR). We show that the SPAR-encoding lncRNA is highly expressed in a subset of tissues and use CRISPR/Cas9 engineering to develop a SPAR-polypeptide-specific knockout mouse while maintaining expression of the host lncRNA. We find that the SPAR-encoding lncRNA is downregulated in skeletal muscle upon acute injury, and using this in vivo model we establish that SPAR downregulation enables efficient activation of mTORC1 and promotes muscle regeneration. Our data provide a mechanism by which mTORC1 activation may be finely regulated in a tissue-specific manner in response to injury, and a paradigm by which lncRNAs encoding small polypeptides can modulate general biological pathways and processes to facilitate tissue-specific requirements, consistent with their restricted and highly regulated expression profile.
尽管长非编码 RNA(lncRNA)根据定义是非蛋白质编码转录物,但最近的研究表明,lncRNA 中存在一部分假定的小开放阅读框可以被翻译。然而,这些隐藏多肽的生物学意义仍不清楚。在这里,我们鉴定并功能表征了 lncRNA LINC00961 编码的一种新型多肽。这种多肽在人类和小鼠之间保守,定位于晚期内体/溶酶体,并与溶酶体 v-ATPase 相互作用,负调控 mTORC1 的激活。这种对 mTORC1 的调控是特定于氨基酸刺激激活 mTORC1,而不是生长因子。因此,我们将这种多肽命名为“氨基酸反应的小调节多肽”(SPAR)。我们表明,该 SPAR 编码 lncRNA 在一组组织中高度表达,并使用 CRISPR/Cas9 工程开发 SPAR 多肽特异性敲除小鼠,同时保持宿主 lncRNA 的表达。我们发现,SPAR 编码 lncRNA 在急性损伤后骨骼肌中下调,并且使用这种体内模型,我们确定 SPAR 下调能够有效地激活 mTORC1,并促进肌肉再生。我们的数据提供了一种机制,通过该机制,mTORC1 的激活可以在组织特异性方式下精细调节,以响应损伤,并且证明 lncRNA 编码小多肽可以调节一般的生物学途径和过程,以促进组织特异性需求,这与它们受限和高度调控的表达谱一致。